Thomas Ebeling

Thomas Ebeling

Director/Board Member at CULLINAN THERAPEUTICS, INC.

Net worth: 1 M $ as of 30/03/2024

65 year
Health Technology
Finance
Consumer Services

Profile

Thomas Ebeling is the founder of Betterlifehealthcare Ltd.
(founded in 2015), Heilpflanzenwohl AG (founded in 2016), and Te Convest AG (founded in 2018).
He is currently the Chairman of the Fund at Remagine Media Ventures, Chairman at Galderma Group AG, Director at Sivantos, Inc. (Canada), Director at Galderma Holding SA, Director at ClearVAT AG, Director at Triangle Holding III SARL, Director at SHL Medical AG, Director at Orna Therapeutics, Inc. (since 2022), Independent Director at Cullinan Oncology, Inc. (since 2017), Advisor at MPM BioImpact, Inc, Member-Supervisory Board at Schwandorfer Rohstoff- und Recycling GmbH, and Board Member & Strategic Advisor at Moonfare GmbH (since 2018).
His former positions include Chairman-Executive Board & CEO at ProSiebenSat.1 Media SE (2009-2017), Chief Executive Officer-Pharmaceuticals Division at Novartis AG (2000-2007), Chief Executive Officer at Novartis Pharmaceuticals Corp.
(2000-2007), Chief Executive Officer at Novartis Consumer Health, Inc. (2007-2008), Chief Executive Officer at Novartis Nutrition GmbH (1998-2000), Chairman at Auris Luxembourg III SA, Chairman-Supervisory Board at Apleona GmbH, Chairman-Supervisory Board at Ostbayerische Verwertungs- und Energieerzeugungsgesellschaft, Director at Idenix Pharmaceuticals LLC, Independent Director at Lonza Group AG (2013-2017), Director-National Sales & Franchise at PepsiCo Deutschland GmbH (1994-1996), Director at EQT AB, Independent Non-Executive Director at Ocean Outdoor Ltd.
(2018-2021), Independent Director at Cullinan Oncology LLC, Member-Supervisory Board at QIAGEN NV, and Member-Supervisory Board at Bayer AG (2012-2019).
He holds an undergraduate degree from the University of Hamburg (1986).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/02/2024 67,504 ( 0.16% ) 1 M $ 30/03/2024
27/02/2023 0 ( -.--% ) - $ 30/03/2024

Thomas Ebeling active positions

CompaniesPositionStart
CULLINAN THERAPEUTICS, INC. Director/Board Member 31/07/2017
Remagine Media Ventures/Germany/ Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 08/03/2022
Consultant / Advisor -
Director/Board Member -
Director/Board Member 31/12/2015
Triangle Holding III SARL Director/Board Member -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Thomas Ebeling

Former positions of Thomas Ebeling

CompaniesPositionEnd
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Thomas Ebeling's experience

Training of Thomas Ebeling

University of Hamburg Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Ebeling's experience

Connections

100 +

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
QIAGEN N.V.

Health Technology

BAYER AG

Health Technology

PROSIEBENSAT.1 MEDIA SE

Consumer Services

NOVARTIS AG

Health Technology

LONZA GROUP AG

Health Technology

EQT AB

Finance

CULLINAN THERAPEUTICS, INC.

Health Technology

Private companies24

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Consumer Non-Durables

Retail Trade

Health Technology

Finance

Commercial Services

Commercial Services

Finance

Finance

Industrial Services

Transportation

Heilpflanzenwohl AG

Te Convest AG

Finance

Triangle Holding III SARL

Health Technology

Health Technology

Remagine Media Ventures/Germany/

Finance

Novartis Nutrition GmbH

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Thomas Ebeling